Canagliflozin
ATC Code
A10BK02
Canagliflozin
Definition
A C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2) with antihyperglycemic activity. Canagliflozin is also able to reduce body weight and has a low risk for hypoglycemia.
Also known as CANAGLIFLOZIN, JNJ-24831754-ZAE, JNJ-28431754, JNJ-28431754-AAA, TA-7284 — per NCIT
Also identified as
- ATC A10BK02 per RXNORM
- NCIT NCIT:C91018 per NCIT
- SCTID 703676004 per RXNORM
- SCTID 703681008 per RXNORM
- UNII 0SAC974Z85 per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Diabetes mellitus type 2 | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Alimentary part of gastrointestinal system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Pancreas | may treat a disease of this organ | DERIVED · CC BY 4.0 |
2 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.